Sofia has 10 years of experience in clinical research and has successfully conducted many full service clinical studies in accordance with ICH-GCP and the appropriate standard operating procedures. She also has a wide experience of studies in numerous indications including cardiology (atrial fibrillation and stroke), hematology (venous thromboembolism), oncology (ALL, breast, OB/GYN, liver, and lung), ophthalmology (glaucoma) and rare disease (adenosine deaminase severe combined immunodeficiency).
Prior to joining Evidera, Sofia worked on investigator led and sponsored pre- and post-market clinical studies in academia, charity and National Health Service in the UK. At Evidera she is responsible for oversight of clinical operations and quality management of a number of non-interventional projects including chart review and EMR studies, registries, long term follow-up, risk minimization measures surveys and post-authorisation safety studies. At the Thrombosis Research Institute she worked to set-up and manage large global Phase IV prospective outcomes disease and treatment registries – notably for managing the clinical operations for sites based in France, Spain and the UK. There she was responsible for creating and developing processes for successful clinical study execution from start-up, to the recruitment phase, data monitoring and led a team of in-house and home-based of CRAs, whilst ensuring that study milestones and deliverables were achieved according to agreed quality standards and regulations. Her other work experience includes Barts Cancer Institute, Moorfields Eye Hospital NHS Foundation Trust, and BioMed Central Ltd.